Searched for
MUMBAI BASED GLENMARK
Glenmark launches biosimilar Adalimumab in IndiaGlenmark did not give any financial detail for the drug, but globally Adalimumab is estimated to be a $16 billion drug in 2016, making it t...04 Jan, 2018, 01.58 PM IST- Kurt Stoeckli to head Glenmark's global research portfolioBased out of Switzerland, Stoeckli will lead Glenmark’s global research portfolio, including biologics (NBEs) and small molecules (NCEs), t...13 Oct, 2016, 07.23 PM IST
- Blow to Glenmark: Delhi High Court restrains it from making Zita & Zita-MetHC restrained Glenmark from making, selling, advertising, distributing or exporting its anti-diabetes drugs Zita and Zita-Met.08 Oct, 2015, 03.49 AM IST
- Glenmark Pharmaceuticals discovers new molecule; enters oncology segmentGlenmark announced the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a state...20 Aug, 2014, 06.00 PM IST
- Glenmark joins pharma companies setting up US plantsOver the years, leading companies like Ranbaxy, Sun Pharma and Dr Reddy's have either invested in greenfield facilities or acquired existin...15 Jul, 2014, 12.19 PM IST
- Glenmark's anti-diabetes drugs shake up Indian anti-diabetes marketThe company has raked in Rs 16 crore in just 8 months since drug was launched.09 Jan, 2014, 05.08 AM IST
- Glenmark gets USFDA nod for alcohol abstinence drugGlenmark Pharma said it has received US health regulator's approval to market generic version of Forest Laboratories' Campral Delayed Relea...12 Aug, 2013, 11.33 AM IST
- No interim relief to Merck against Glenmark’s diabetes genericsDelhi High Court has refused to bar Glenmark from selling the generic versions of anti-diabetic drugs manufactured by Merck Sharp & Dohme.06 Apr, 2013, 06.02 AM IST
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.14 Dec, 2011, 04.07 AM IST
- Merck, Glenmark end cholesterol drug rowCos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.12 May, 2010, 04.24 AM IST
- Glenmark enters into licence, supply pact with Taro PharmaPharma firm Glenmark Pharmaceuticals on Thursday said that it has entered into a licencing agreement with US-based Taro Pharmaceuticals Inc...06 May, 2010, 11.10 AM IST
- Glenmark in licensing deal with US co for cholesterol drugDrug firm Glenmark on Tuesday said it has signed an exclusive licensing agreement with the US-based Par Pharmaceutical to sell generic chol...04 May, 2010, 04.49 PM IST
- Glenmark Generics files for IPOGlenmark Generics, the generics arm of Glenmark Pharmaceuticals, on Wednesday filed the draft prospectus with Sebi to raise Rs 550-600 cror...01 Oct, 2009, 01.30 AM IST
- Teva, Glenmark call an end to patent disputeIsraeli generic major Teva and Mumbai-based Glenmark Pharmaceuticals have settled a patent dispute over various generic versions of Coreg -...23 Apr, 2009, 01.14 AM IST
- Glenmark confirms patent challenge of fluticasone lotionGlenmark Generics Ltd's US subsidiary confirmed Nycomed US filed a patent infringement lawsuit on Dec 12, 2008, in the US District Court, E...17 Dec, 2008, 02.16 PM IST
- Glenmark Pharma inks deal with MeyerZall LabsDrug maker Glenmark Pharmaceuticals Ltd has signed a 10-year marketing and distribution rights agreement with South Africa-based MeyerZall ...25 Oct, 2007, 01.05 PM IST
- Glenmark gets nod to sell Zofran generic in USGlenmark Pharmaceuticals has received final approval to market a generic version of GlaxoSmithKline’s popular anti-emetic drug Zofran, that...30 Jun, 2007, 02.44 AM IST
Load More
